Cargando…
The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinoma
BACKGROUND: Enhancer of Zeste homologue 2 (EZH2) is a polycomb group gene and an epigenetic regulator that inhibits transcription, a modification associated with gene silencing. EZH2 plays an essential role in humoral and cell-mediated adaptive immunity. The purpose of the current study is to invest...
Autores principales: | Wu, Shi-yi, Xie, Zhao-yu, Yan, Lu-yu, Liu, Xiao-fang, Zhang, Yue, Wang, Da-an, Dong, Jie, Sun, Hong-tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166340/ https://www.ncbi.nlm.nih.gov/pubmed/35659256 http://dx.doi.org/10.1186/s12865-022-00502-7 |
Ejemplares similares
-
Correlation of MKI67 with prognosis, immune infiltration, and T cell exhaustion in hepatocellular carcinoma
por: Wu, Shi-yi, et al.
Publicado: (2021) -
Mutual regulation between CHD5 and EZH2 in hepatocellular carcinoma
por: Xie, Cheng-Rong, et al.
Publicado: (2015) -
High Expression of EZH2 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma
por: Chen, Zhitao, et al.
Publicado: (2022) -
EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies
por: Wang, Bohan, et al.
Publicado: (2023) -
NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)